Edith Ye Tak Ho, MD
Gastroenterology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 2 carriers
- Offices
- 3
Offices
3 locations · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
13 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ho’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
13 of 13 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A105337 · Current
Licensed to practise in California · since 2008 · expires 2028-01-31 · University of Toronto Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$28,330
Medicare paid this office $28,330 for 123 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 32 | $6,678 | $167 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 30 | $3,469 | $116 |
| New patient visit (60+ min) | 12 | $2,288 | $191 |
| Biopsy of large bowel using a flexible endoscope | 18 | $2,114 | $117 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $1,803 | $106 |
See all 8 services
| Long return visit (40+ min) | 32 | $6,678 | $167 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 30 | $3,469 | $116 |
| New patient visit (60+ min) | 12 | $2,288 | $191 |
| Biopsy of large bowel using a flexible endoscope | 18 | $2,114 | $117 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $1,803 | $106 |
| New patient visit (45+ min) | 14 | $1,639 | $117 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $999 | $83 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 25 | $386 | $15 |
Procedures Medicare counted
| Colonoscopy | 19 | More than 47% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 28 | More than 55% of doctors who do this |
Who their Medicare patients are
123 Original Medicare patients in 2024. Average age 72 · Under 65 18% · 85 and older 12% · Women 63% · Also on Medicaid 35% · Health risk score 2.65. Sicker patients than 9 in 10 peers; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 75% · Chronic kidney disease 42% · Diabetes 40% · Coronary heart disease 37% · Heart failure 33% · Depression 31% · COPD 26% · Atrial fibrillation 26% · Cancer 24% · Dementia 20% · Stroke 14%.
The office billed $254,768, Medicare allowed $36,474 and paid $28,330; for 241 services of 28 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 123 | 241 | 72 | 2.65 | $254,768 | $28,330 |
| 2023 | 152 | 325 | 71 | 2.25 | $319,317 | $36,773 |
| 2022 | 104 | 214 | 71 | 1.80 | $235,095 | $25,953 |
| 2021 | 71 | 155 | 71 | 1.86 | $170,461 | $17,809 |
| 2020 | 110 | 266 | 70 | 2.56 | $237,556 | $30,801 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Long return visit (40+ min) | 38 | $5,560 | $124 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 38 | $4,663 | $120 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $4,388 | $110 |
| New patient visit (60+ min) | 27 | $3,846 | $142 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,004 | $154 |
| Biopsy of large bowel using a flexible endoscope | 18 | $1,926 | $107 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 17 | $1,925 | $107 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,824 | $73 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 16 | $1,380 | $81 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 11 | $52 | $5 |
2022: 6 services
| Long return visit (40+ min) | 36 | $5,847 | $130 |
| New patient visit (60+ min) | 29 | $3,993 | $138 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,455 | $182 |
| Biopsy of large bowel using a flexible endoscope | 20 | $2,626 | $131 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 14 | $1,109 | $79 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 16 | $75 | $5 |
2021: 4 services
| New patient visit (60+ min) | 24 | $4,336 | $181 |
| Long return visit (40+ min) | 21 | $4,008 | $129 |
| Biopsy of large bowel using a flexible endoscope | 18 | $2,546 | $141 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 19 | $76 | $4 |
2020: 7 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 42 | $7,788 | $185 |
| Long return visit (40+ min) | 25 | $3,280 | $109 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 19 | $2,778 | $96 |
| New patient visit (60+ min) | 17 | $2,336 | $137 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,320 | $66 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $1,284 | $107 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 14 | $69 | $5 |
Medicaid work
$1,249 in 2024
Medicaid paid $1,249 for 12 billed services this clinician did in 2024, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| IP/OBS CONSLTJ NEW/EST PT MOD MDM 60 MINUTES | 12 | $1,249 |
| 2024 | 12 | 1 | 12 | $1,249 |
Drugs they prescribed that Part D paid
$472,829
Pharmacies billed $472,829 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
101 generic and 49 brand-name prescriptions · $472,829 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Stelara | 13 | $312,340 | $24,026 |
| Mesalamine | 14 | $2,606 | $186 |
| Peg 3350-Electrolyte | 16 | $352 | $22 |
| Famotidine | 16 | $184 | $12 |
| Omeprazole | 14 | $119 | $9 |
Year by year
| 2024 | 150 | 58 | None | 33% | $472,829 |
| 2023 | 196 | 62 | 0% (0) | None | $310,017 |
| 2022 | 157 | 59 | 0% (0) | 34% | $212,233 |
| 2021 | 100 | 46 | 0% (0) | 32% | $99,018 |
| 2020 | 63 | 28 | 0% (0) | 27% | $8,569 |
| 2013 | 27 | None | 0% (0) | None | $1,575 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Mesalamine | 11 | $6,380 | $580 |
| Omeprazole | 22 | $841 | $38 |
| Loperamide | 13 | $749 | $58 |
| Esomeprazole Magnesium | 12 | $736 | $61 |
| Pantoprazole | 20 | $474 | $24 |
| Peg 3350-Electrolyte | 16 | $360 | $22 |
| Famotidine | 23 | $307 | $13 |
2022: 5 drugs
| Humira | 12 | $79,350 | $6,613 |
| Omeprazole | 19 | $830 | $44 |
| Peg 3350-Electrolyte | 28 | $442 | $16 |
| Dicyclomine | 12 | $410 | $34 |
| Famotidine | 25 | $262 | $10 |
2021: 3 drugs
| Humira(Cf) | 12 | $77,762 | $6,480 |
| Peg 3350-Electrolyte | 14 | $239 | $17 |
| Famotidine | 17 | $234 | $14 |
2020: 1 drug
| Pantoprazole | 12 | $111 | $9 |
Money from drug and device companies
$338 in 2025
| 2025 | 4 | 5 | None | $338 |
| 2024 | 1 | 1 | None | $53 |
| 2023 | 1 | 1 | None | $109 |
| 2022 | 1 | 1 | None | $118 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| 3-D Matrix | None | $235 | 1 payment
|
| Abbvie | Rinvoq | $57 | 1 payment
|
| Mauna Kea Technologies | None | $29 | 1 payment
|
| Janssen Scientific Affairs | Tremfya | $16 | 1 payment
|
See all 4 published payments
| 3-D Matrix | Meals · 2025-12-10 | None | $235 |
| Mauna Kea Technologies | Meals · 2025-07-21 | None | $29 |
| Abbvie | Meals · 2025-02-07 | Rinvoq | $57 |
| Janssen Scientific Affairs | Meals · 2025-02-06 | Tremfya | $16 |
See earlier years (2024, 2023, 2022)
2024: $53
| Abbvie | Rinvoq | $53 | 1 payment
|
2023: $109
| Abbvie | Rinvoq | $109 | 1 payment
|
2022: $118
| Abbvie | Rinvoq | $118 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1942481619
- Licence
- CA A105337California A105337: Current · expires 2028-01-31
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2007-11-21
- NPI last updated
- 2024-04-26
- NPI record certified
- 2024-04-26
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 430 Broadway St # Mc6341, Redwood City, CA, 94063